bioAffinity Technologies, Inc. (BIAF)
USD 1.04
(1.96%)
USD 1.04
(1.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.62 Million USD | -32.68% |
| 2022 | -5.6 Million USD | -294.21% |
| 2021 | -2.2 Million USD | 78.48% |
| 2020 | -6.86 Million USD | -124.83% |
| 2019 | -3.04 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.93 Million USD | -8.21% |
| 2024 Q1 | -1.79 Million USD | 18.75% |
| 2023 Q2 | -1.71 Million USD | -11.48% |
| 2023 FY | - USD | -32.68% |
| 2023 Q4 | -2.19 Million USD | 2.26% |
| 2023 Q3 | -2.24 Million USD | -31.05% |
| 2023 Q1 | -1.53 Million USD | 2.18% |
| 2022 Q2 | 312.25 Thousand USD | 197.2% |
| 2022 Q1 | -321.23 Thousand USD | 62.55% |
| 2022 FY | - USD | -294.21% |
| 2022 Q4 | -1.57 Million USD | 61.02% |
| 2022 Q3 | -4.02 Million USD | -1390.39% |
| 2021 Q3 | -1.37 Million USD | -186.16% |
| 2021 FY | - USD | 78.48% |
| 2021 Q4 | -857.72 Thousand USD | 37.72% |
| 2021 Q1 | -601.04 Thousand USD | 24.81% |
| 2021 Q2 | 1.59 Million USD | 365.97% |
| 2020 FY | - USD | -124.83% |
| 2020 Q4 | -799.37 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 96.428% |
| Prenetics Global Limited | -47.89 Million USD | 84.071% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -352.241% |
| CareDx, Inc | -89.65 Million USD | 91.491% |
| Exact Sciences Corporation | 41.87 Million USD | 118.219% |
| Exagen Inc. | -19.15 Million USD | 60.167% |
| Inotiv, Inc. | -26.5 Million USD | 71.217% |
| Guardant Health, Inc. | -433.3 Million USD | 98.239% |
| Biodesix, Inc. | -37.1 Million USD | 79.437% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -206.994% |
| Precipio, Inc. | -4.31 Million USD | -76.686% |
| iSpecimen Inc. | -9.1 Million USD | 16.196% |
| Natera, Inc. | -383.27 Million USD | 98.009% |
| Aspira Women's Health Inc. | -16.49 Million USD | 53.737% |
| Standard BioTools Inc. | -54.45 Million USD | 85.99% |
| 23andMe Holding Co. | -291.87 Million USD | 97.386% |
| Castle Biosciences, Inc. | -45.02 Million USD | 83.055% |
| Personalis, Inc. | -96.8 Million USD | 92.119% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 93.511% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | 20.454% |
| OpGen, Inc. | -29.51 Million USD | 74.148% |
| T2 Biosystems, Inc. | -43.87 Million USD | 82.611% |
| Myriad Genetics, Inc. | -67.8 Million USD | 88.747% |
| ICON Public Limited Company | 1.63 Billion USD | 100.468% |
| NeoGenomics, Inc. | -17.6 Million USD | 56.669% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -352.241% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 100.627% |
| RadNet, Inc. | 292.78 Million USD | 102.606% |
| MDxHealth SA | -30.46 Million USD | 74.96% |
| Psychemedics Corporation | -251 Thousand USD | -2939.564% |
| Illumina, Inc. | -608 Million USD | 98.745% |
| Check-Cap Ltd. | -17.64 Million USD | 56.772% |
| Twist Bioscience Corporation | -176.7 Million USD | 95.682% |
| DarioHealth Corp. | -53.49 Million USD | 85.738% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 83.611% |
| Sera Prognostics, Inc. | -35.28 Million USD | 78.379% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | 22.029% |
| OPKO Health, Inc. | -65.51 Million USD | 88.355% |
| Medpace Holdings, Inc. | 363.15 Million USD | 102.101% |
| Neogen Corporation | 182.59 Million USD | 104.178% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | 13.409% |
| Prenetics Global Limited | -47.89 Million USD | 84.071% |
| Mainz Biomed B.V. | -25.01 Million USD | 69.496% |
| Trinity Biotech plc | -24.09 Million USD | 68.341% |
| Neuronetics, Inc. | -22.75 Million USD | 66.478% |
| Sotera Health Company | 514.14 Million USD | 101.484% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -0.0% |